JMP Securities downgraded Anthera Pharmceuticals Inc. (Nasdaq: ANTH) from Outperform to Market Perform sending the stock price plummeting $1.92 to $0.83.
Anthera Downgraded
June 28, 2012 at 14:12 PM EDT
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.